Xofluza™ (baloxavir marboxil) – New drug approval
October 24, 2018 - The FDA announced the approval Genentech’s Xofluza (baloxavir marboxil), for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours.
Download PDF
